Answers are grounded in this paper and cite their sources.
Background Differentiating benign sclerosing angiomatoid nodular transformation (SANT) from solitary mass-forming primary splenic lymphoma (PSL) remains challenging because both can present as solitary splenic masses with overlapping imaging features. This study evaluated quantitative clinicopathologic and imaging features that may help distinguish these entities. Methods We retrospectively analyzed 11 patients with histologically confirmed SANT and 11 patients with solitary mass-forming PSL, selected from an institutional cohort of 100 consecutive PSL cases that presented as a solitary splenic mass. Demographic, radiologic, and pathologic variables were evaluated. Receiver operating characteristic analysis was used to evaluate the diagnostic performance of selected individual preoperative variables. Results Patients with solitary mass-forming PSL were significantly older than those with SANT (mean 53.3 vs. 37.9 years; p = 0.038) and exhibited substantially higher Ki-67 proliferation indices (63.3% vs. 4.4%; p = 0.003). Although focal lesion size did not differ significantly between the groups, whole-spleen burden was a major discriminator: maximal spleen diameter (18.4 vs. 12.0 cm; p = 0.015) and weight (1250 vs. 214 g; p = 0.036) were markedly higher in lymphoma. Spleen size alone achieved an area under the curve of 0.867, with a 16 cm threshold yielding 62.5% sensitivity and 100% specificity. Conclusions Solitary mass-forming PSL is characterized by whole-organ diffuse enlargement rather than focal lesion size, distinguishing it from localized SANT. Global splenic burden may provide an adjunctive imaging parameter for distinguishing solitary mass-forming PSL from SANT and may complement other clinical, imaging, and tissue-based assessments.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: